The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The aim of this study was to determine the frequency and severity of persistent liver biochemistry abnormalities in DILI patients followed over 2 years
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Background & Aims: It is not known if specific characteristics of medication are associated with ...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
BACKGROUND & AIMS: The Drug-Induced Liver Injury Network is conducting a prospective study of patien...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failur...
Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failur...
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
Chronic outcome following acute idiosyncratic drug-induced liver injury (DILI) is not yet defined. T...
Drug-induced liver injury (DILI) is an important cause of death and indication for liver transplanta...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Background & Aims: It is not known if specific characteristics of medication are associated with ...
The long-term outcomes of patients with drug induced liver injury (DILI) are not well described. The...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
Little is known about the incidence of drug-induced liver injury (DILI) and risk factors for adverse...
BACKGROUND & AIMS: The Drug-Induced Liver Injury Network is conducting a prospective study of patien...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
The drug-induced liver injury network (DILIN) is conducting a prospective study of patients with DIL...
Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failur...
Idiosyncratic drug-induced liver injury (DILI) is among the most common causes of acute liver failur...
Background and Aims Idiosyncratic drug-induced liver injury (DILI) is among the most common causes o...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
Chronic outcome following acute idiosyncratic drug-induced liver injury (DILI) is not yet defined. T...
Drug-induced liver injury (DILI) is an important cause of death and indication for liver transplanta...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Drug-induced liver injury (DILI) remains a significant clinical challenge and is the leading cause o...
Background & Aims: It is not known if specific characteristics of medication are associated with ...